Open Journal of Obstetrics and Gynecology

Volume 2, Issue 2 (June 2012)

ISSN Print: 2160-8792   ISSN Online: 2160-8806

Google-based Impact Factor: 0.37  Citations  h5-index & Ranking

Identification of interleukin-6 (IL-6) and squamous cell carcinoma (SCC) as amniotic fluid-specific markers

HTML  XML Download Download as PDF (Size: 595KB)  PP. 147-150  
DOI: 10.4236/ojog.2012.22028    3,780 Downloads   6,160 Views  Citations

ABSTRACT

Objective: To determine if an amniotic fluid (AF)-specific marker is present and if its concentration changes with the presence of labor. Study Design: Twenty-six healthy women who gave birth to healthy newborns at term during the period from July 2009 to January 2010 were included in the study. Six candidate markers were assessed by commercially available ELISA kits: interleukin (IL)-6, squamous cell carcinoma (SCC) antigen, insulin-like growth factor (IGFBP)-1, osteopontin (OPN), CA125, and sialyl Tn (STN). Results: The AF/maternal serum (MS) measurement based on IL-6 or SCC has proved to be superior to IGFBP-1, CA125, OPN and STN. Women with spontaneous labor at term had significantly higher IL-6 and IGFBP-1 concentrations in AF compared with those without labor. No significant differences were observed in the AF concentrations of SCC, OPN, CA125 and STN between women with labor and those not in labor. Conclusion: Our observation of IL-6 and SCC in AF may open a new area of research to assess their usefulness as biological markers of obstetrical disorders.

Share and Cite:

Naruse, K. , Noguchi, T. , Yoshida, S. , Tsunemi, T. , Shigetomi, H. , Oi, H. and Kobayashi, H. (2012) Identification of interleukin-6 (IL-6) and squamous cell carcinoma (SCC) as amniotic fluid-specific markers. Open Journal of Obstetrics and Gynecology, 2, 147-150. doi: 10.4236/ojog.2012.22028.

Cited by

[1] Dynamic changes in the levels of maternal serum squamous cell carcinoma antigen, a potential biomarker of amniotic fluid embolism, before and after delivery in …
2021
[2] 妊娠中の母体血中 SCC 抗原, 羊水中 SCC 抗原, 及び, 分娩時出血量の検討─ 子宮型羊水塞栓症の解明に向けて─
… 周産期・新生児医学会 …, 2021
[3] Squamous cell carcinoma antigen as a novel candidate marker for amniotic fluid embolism
Journal of Obstetrics and Gynaecology Research, 2017
[4] Evaluation of vaginal fluid squamous cell carcinoma antigen test in diagnosis of premature rupture of membranes
The Journal of Maternal-Fetal & Neonatal Medicine, 2016
[5] Amniotic Fluid Embolism: Anaphylactic Reactions With Idiosyncratic Adverse Response
Obstetrical & gynecological survey, 2015
[6] Incidence, diagnosis and pathophysiology of amniotic fluid embolism
Journal of Obstetrics & Gynaecology, 2014
[7] Challenges in managing amniotic fluid embolism: An up-to-date perspective on diagnostic testing with focus on novel biomarkers and avenues for future research
Current pharmaceutical biotechnology, 2013

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.